TG Therapeutics, Inc. - Special Call Transcript
Greetings, and welcome to the TG Therapeutics UNITY-NHL trial update call. (Operator Instructions) Please note this conference is being recorded. I would now like to turn the conference over to your host today Ms. Jenna Bosco, Senior Vice President of Corporate Communications. Please go ahead, Ms. Bosco.
Thank you. Good morning, and welcome to our conference call regarding the positive outcome from the marginal zone lymphoma cohort of the UNITY-NHL trial. I'm Jenna Bosco, TG's Senior Vice President of Corporate Communications, and I welcome you all to our call today.
Following our safe harbor statement, Michael Weiss, the company's Executive Chairman and Chief Executive Officer will provide an update regarding the UNITY-NHL news announced this morning as well as offer a brief update on the company's overall standing.
Before we begin, I would like to remind everyone that various remarks that we make about our future expectations, plans and prospects
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |